Not finding it? Sign in to also search OpenAlex live.
-
PSMA PET/CT for treatment response evaluation at predefined time points is superior to PSA response for predicting survival in metastatic castration-resistant prostate cancer patients2024 European Journal of Radiology article Medicine Prostate Cancer Treatment and Research Open access
Fleur Kleiburg, Lioe‐Fee de Geus‐Oei, Saskia A. C. Luelmo, Jelle J. Goeman, Frits Smit, Tom van der Hulle, +1 more
22citations -
AB0898 Guselkumab improves dactylitis in PsA patients with inadequate response to TNFi: data from the Phase 3b COSMOS trial2022 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Helena Marzo‐Ortega, E. Theander, M. Neuhold, P. Bergmans, M. Shawi, Michelle Perate, +3 more
0citations -
LB0010 INHIBITION OF STRUCTURAL DAMAGE PROGRESSION WITH GUSELKUMAB, A SELECTIVE IL-23i, IN PARTICIPANTS WITH ACTIVE PsA: RESULTS THROUGH WEEK 24 OF THE PHASE 3b, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED APEX STUDY2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Philip J. Mease, Christopher T. Ritchlin, Laura C. Coates, A. Kollmeier, Bin Zhou, Y. Jiang, +4 more
3citations -
LB0001 EFFICACY AND SAFETY OF DEUCRAVACITINIB UP TO WEEK 16 FROM POETYK PsA-1: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Désirée M F M van der Heijde, Philip J. Mease, Carle F. Paul, F. Behrens, Laure Gossec, Yuichiro Kaneko, +15 more
4citations -
Efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with active psoriatic arthritis: 52-week results from the randomised, double-blind, placebo-controlled phase 3 POETYK PsA-1 trial2026 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Désirée M F M van der Heijde, Philip J. Mease, Carle F. Paul, Frank Behrens, Laure Gossec, Yuko Kaneko, +16 more
2citations -
Inhibition of structural damage progression with the selective interleukin-23 inhibitor guselkumab in participants with active PsA: results through week 24 of the phase 3b, randomised, double-blind, placebo-controlled APEX study2025 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Philip J. Mease, Christopher T. Ritchlin, Laura C. Coates, Alexa P. Kollmeier, Bei Zhou, Yusang Jiang, +6 more
10citations -
OP0054 EFFICACY OF GUSELKUMAB, A MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO THE P19-SUBUNIT OF IL-23, ON ENDPOINTS RELATED TO AXIAL INVOLVEMENT IN PATIENTS WITH ACTIVE PSA WITH IMAGING-CONFIRMED SACROILIITIS: WEEK-24 RESULTS FROM TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES2020 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access cited by 2 patents
Philip Helliwell, Dafna D. Gladman, Denis Poddubnyy, Philip J. Mease, Xenofon Baraliakos, Alexa P. Kollmeier, +9 more
14citations -
Plasma metabolomics reveals candidate biomarkers associated with individual treatment response in psoriatic arthritis2026 Arthritis Research & Therapy article Medicine Spondyloarthritis Studies and Treatments Open access
Mieke L M Bentvelzen, Wei Yang, Yu Zhang, Alida S. D. Kindt, Amy C. Harms, Julia Spierings, +22 more
0citations -
Factors predicting biochemical response and survival benefits following radioligand therapy with [177Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer: a review2021 European Journal of Nuclear Medicine and Molecular Imaging article Medicine Radiopharmaceutical Chemistry and Applications Open access
Reyhaneh Manafi‐Farid, Sara Harsini, Bahare Saidi, Hojat Ahmadzadehfar, Ken Herrmann, Alberto Briganti, +2 more
49citations -
Response to treatment in psoriatic arthritis, the effect of age: analysis of patients receiving ustekinumab in the PsABio real-world study2023 Arthritis Research & Therapy article Medicine Spondyloarthritis Studies and Treatments Open access
Laure Gossec, Elke Theander, Soumya D. Chakravarty, Paul Bergmans, F. Lavie, Wim Noël, +3 more
3citations -
Biochemical Response of <0.1 ng/ml Predicts Therapy-free Survival of Prostate Cancer Patients following Prostate-specific Membrane Antigen–targeted Salvage Surgery
Sophie Knipper, Flemming Lischewski, Daniel Koehler, Matthias J. Eiber, Fijs W. B. van Leeuwen, Hilda A. de Barros, +14 more
21citations -
A European, prospective, observational study of enzalutamide in patients with metastatic castration‐resistant prostate cancer: PREMISE2021 International Journal of Cancer article Medicine Prostate Cancer Treatment and Research Open access
Heather Ann Payne, Angus Robinson, Bernard Rappe, Serena Hilman, Ugo De Giorgi, Steven Joniau, +13 more
18citations -
Interobserver variability, detection rate, and lesion patterns of 68Ga-PSMA-11-PET/CT in early-stage biochemical recurrence of prostate cancer after radical prostatectomy2020 European Journal of Nuclear Medicine and Molecular Imaging article Medicine Prostate Cancer Diagnosis and Treatment Open access
Jonathan Miksch, Dirk Bottke, Thomas Krohn, Reinhard Thamm, Detlef Bartkowiak, Christoph Solbach, +5 more
46citations -
An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer2021 Pharmacology Research & Perspectives article Medicine Prostate Cancer Treatment and Research Open access
Josephina P. M. Vrouwe, Ingrid M. C. Kamerling, Michiel Joost van Esdonk, Josbert M. Metselaar, Frederik E. Stuurman, Gabri van der Pluijm, +2 more
5citations -
Robot-assisted Prostate-specific Membrane Antigen–radioguided Salvage Surgery in Recurrent Prostate Cancer Using a DROP-IN Gamma Probe: The First Prospective Feasibility Study2022 European Urology article Medicine Prostate Cancer Diagnosis and Treatment Open access cited by 3 patents
Hilda A. de Barros, Matthias N. van Oosterom, Maarten L. Donswijk, Jeroen J. M. A. Hendrikx, André N. Vis, Tobias Maurer, +3 more
74citations -
POS1325 UNLOCKING THE POTENTIAL OF LIPIDOMICS FOR PREDICTIVE TREATMENT STRATEGIES IN PSORIATIC ARTHRITIS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Mieke L M Bentvelzen, Yuhong Zhang, Amy C. Harms, H.E. Vonkeman, Shasti C. Mooij, Lydia G. Schipper, +3 more
0citations -
The effect of guselkumab on inhibiting radiographic progression in patients with active psoriatic arthritis: study protocol for APEX, a Phase 3b, multicenter, randomized, double-blind, placebo-controlled trial
Christopher T. Ritchlin, Laura C. Coates, Philip J. Mease, Désirée M F M van der Heijde, Jiao Song, Yusang Jiang, +3 more
12citations -
Highly selective tyrosine kinase 2 inhibition with zasocitinib (TAK-279) improves outcomes in patients with active psoriatic arthritis: a randomised phase 2b study2025 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Alan Kivitz, Xenofon Baraliakos, Elena Tomaselli Muensterman, Arthur Kavanaugh, Désirée M F M van der Heijde, Piotr Adrian Klimiuk, +10 more
11citations -
Long‐Term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin‐23, Through Two Years: Results From a Phase III , Randomized, Double‐Blind , Placebo‐Controlled Study Conducted in Biologic‐Naive Patients With Active Psoriatic Arthritis2021 Arthritis & Rheumatology article Medicine Spondyloarthritis Studies and Treatments Open access cited by 1 patent
Iain B. McInnes, Proton Rahman, Alice Bendix Gottlieb, Elizabeth C. Hsia, Alexa P. Kollmeier, Xie Lillian Xu, +6 more
104citations